Livemedia Home
facebook_icon twitter_icon youtube_icon instagram rss_icon

 Login / Register to Livemedia


A+ | A-
GR | GLOBAL | UK

04/05/2019 Congresses | Video | Transcatheter Heart Valves Greece 2019 | A. Tzifa | Transcatheter valve-in-valve and valve-in-ring in the tricuspid position. Patient selection, tips and tricks and outcomes

Share

10.434 total
707 live
44 video
2.235 photo
Views:

4/5Αίθουσα Banquet Hall, MAICC -
17:30-19:00 Mitral and Tricuspid Session II – Looking to the future
Πρόεδροι: N. Georgakopoulos,S. Kyrzopoulos,G. Makos,A. Patrianakos
17:30-17:45 Advanced echocardiography assessment of the tricuspid valve and right ventricular function and implications for transcatheter treatment
M. Chrissoheris
17:45-18:00 Technical tips and tricks to successful perform transseptal puncture for Mitraclip and TMVR procedures
K. Spargias
18:00-18:15 An often Challenging MitraClip Decision: Whether to Implant a second (or third) Clip
V. Ninios
18:15-18:30 Transcatheter valve-in-valve and valve-in-ring in the tricuspid position. Patient selection, tips and tricks and outcomes
A. Tzifa
18:30-18:45 Minimally invasive surgery for isolated TR repair
A. Pitsis
18:45-19:00 The Structural Heart and Valve Center: The Roles of Cardiovascular Team Professionals
S. Pattakos
Σχολιαστές: A. Manolis,S. Kounas,G. Moustogiannis


Webtv: THVgreece WebTV
 
Sort by Date | Views

Find it here: Τhe 8th Conference of  Transcatheter Heart Valve Therapies

Don't miss the 8th Conference of  Transcatheter Heart Valve Therapies organized by The Diagnostic and Therapeutic Center of Athens Hygeia to be held on 03 - 04 May 2019 at Athens Concert Hall.


For information please click here.

Webtv: THVgreece WebTV
03/05 Banquet Hall, MAICC
09:00 - 11:00
TAVI Session I – TAVR Technology in a Rapidly-Evolving Era 

Evaluated
Evaluation
09:00 - 09:15
Latest TAVR Randomized Trials

Evaluated
Evaluation

Speaker: G. Pattakos(   )

09:15 - 09:30
High-Quality TAVR: Does a minimum volume requirement still make sense?

Evaluated
Evaluation

Speaker: M. Vavuranakis(   )

09:30 - 09:45
The selection of SAVR devices in the TAVR era

Evaluated
Evaluation

Speaker: S. Prapas(   )

09:45 - 10:00
Rapid Deployment Surgical Valves with Minimally invasive techniques. Can they compete with TAVR?

Evaluated
Evaluation

Speaker: P. Dedeilias

10:00 - 10:15
TAVR for low-risk patients with a self-expanding valve

Evaluated
Evaluation

Speaker: N. Kleiman

10:15 - 10:30
Live-in-a-box TAVR

Evaluated
Evaluation
10:45 - 11:00
Discussion

Chairmen: I. Goudevenos, J. Kanakakis, D. Sionis, P. Vardas

Commentators: S. Karagiannis, G. Makos, A. Tzikas

11:00 - 11:30
WELCOME NOTES 

Evaluated
Evaluation

Chairmen: S. Pattakos, S. Konstantinidis, I. Goudevenos, D. Tousoulis, P. Vardas, A. Kartapanis

11:30 - 13:30
TAVR Session II – TAVR on the Uprise. How do we deal with complex situations? 

Evaluated
Evaluation
12:00 - 12:10
CT Imaging of Bicuspid Aortic Valve Disease. Anatomic patterns favorable and unfavorable for TAVR and factors influencing device selection

Evaluated
Evaluation

Speaker: A. Chalapas(   )

12:10 - 12:20
TAVR will be the treatment of choice for bicuspid aortic valve disease in the future!

Evaluated
Evaluation

Speaker: N. Van Mieghem(   )

12:20 - 12:30
Most Bicuspid aortic valves (especially In younger low-risk patients) will remain in the surgical domain!

Evaluated
Evaluation

Speaker: D. Angouras(   )

12:30 - 12:40
Strokes After TAVR and SAVR: Incidence in the "Modern Era" and Key Messages

Evaluated
Evaluation

Speaker: S. Kodali(   )

12:40 - 12:50
What’s Holding Back Cerebral Embolic Protection in TAVR? Data or Money?

Evaluated
Evaluation

Speaker: R. Mehran(   )

12:50 - 13:00
TAVR in the patient with significant native or bioprosthetic mitral and/or tricuspid valve disease

Evaluated
Evaluation

Speaker: M. Οto

13:00 - 13:15
Live-in-a-box TAVR

Evaluated
Evaluation
13:15 - 13:30
Discussion

Chairmen: M. Argiriou, S. Foussas, E. Pissimisis, C. Tsioufis

Commentators: K. Aznaouridis, V. Androutsopoulou, S. Makrigiannis

13:30 - 14:00
BREAK 

14:00 - 15:45
TAVI Session III – TAVR dilemmas and complications 

Evaluated
Evaluation
14:00 - 14:15
Incidence, predictors and consequences of new LBBB and new PPM after TAVR

Evaluated
Evaluation

Speaker: L. Papavasileiou(   )

14:15 - 14:30
Is paravalvular regurgitation after TAVR still an important consideration in 2019?

Evaluated
Evaluation

Speaker: N. Kleiman(   )

14:30 - 14:45
A Selective versus Routine Minimalist Strategy. Is every patient eligible?

Evaluated
Evaluation

Speaker: S. Kapadia(   )

14:45 - 15:00
Management of Coronary Disease in AS Patients: Important Treatment Considerations (When to consider CABG, timing of PCI and TAVR, and completeness of revascularization)

Evaluated
Evaluation

Speaker: M. Οto

15:00 - 15:15
To crack or not to crack? The role for fracturing bioprosthetic valves during ViV procedures

Evaluated
Evaluation

Speaker: M. Kasel

15:15 - 15:30
Live-in-a-box TAVR

Evaluated
Evaluation
15:30 - 15:45
Discussion

Evaluated
Evaluation

Chairmen: D. Iliopoulos, G. Hahalis, V. Pyrgakis, S. Tzeis

Commentators: I. Chlorogiannis, K. Dimitriadis, A. Zacharoulis

15:45 - 16:00
Break 

Evaluated
Evaluation
16:00 - 17:30
JOINT SESSON I 

Aortic and Mitral Club

Evaluated
Evaluation
16:00 - 16:15
In hospital mortality after TAVR. Common and uncommon causes

Evaluated
Evaluation

Speaker: S. Kodali(   )

16:15 - 16:28
Impact of valvular heart disease on the global burden of heart failure: Can transcatheter therapies make a difference?

Evaluated
Evaluation

Speaker: A. Katsaros(   )

16:28 - 16:40
Patient-prosthesis mismatch after transcatheter aortic valve replacement: prevalence and long-term impact

Evaluated
Evaluation

Speaker: A. Patrianakos(   )

16:40 - 16:52
Moderate aortic stenosis with reduced ejection fraction: Can imaging guide therapy?

Evaluated
Evaluation

Speaker: E. Anagnostou

16:52 - 17:04
Minimally invasive surgery for the Mitral Valve. Hard to Beat!

Evaluated
Evaluation

Speaker: G. Pattakos(   )

17:04 - 17:16
Can Transcatheter Edge-to-Edge, direct or indirect Mitral Rings and Chords Match or Exceed Open Surgical Procedures?

Evaluated
Evaluation

Speaker: S. Kodali(   )

Chairmen: S. Adamopoulos, C. Chrysohoou, G. Filippatos

Commentators: G. Giamouzis, G. Karatasakis

17:30 - 18:30
JOINT KEY LECTURES 

Evaluated
Evaluation
17:30 - 17:50
TAVR for All? New insights from the low-risk trials

Evaluated
Evaluation

Speaker: S. Kapadia(   )

17:50 - 18:10
Defining Secondary Mitral Regurgitation: Get it Right!

Evaluated
Evaluation

Speaker: J. Kisslo

18:10 - 18:30
Mitraclip for Functional Mitral Regurgitation

Evaluated
Evaluation

Speaker: S. Kar(   )

Chairmen: P. Nihoyannopoulos, P. Vardas

18:30 - 20:00
JOINT SESSION II  

Mitral and Tricuspid Club

Evaluated
Evaluation
18:30 - 18:45
Exercise-stress echocardiography and effort intolerance in asymptomatic/symptomatic degenerative mitral regurgitation

Evaluated
Evaluation

Speaker: D. Klettas

18:45 - 19:00
Mitraclip vs. PASCAL. Similarities and differences

Evaluated
Evaluation

Speaker: K. Spargias

19:00 - 19:15
Lessons from the MITRA-FR and COAPT studies; How should we quantify MR?

Evaluated
Evaluation

Speaker: K. Papadopoulos

19:15 - 19:30
Percutaneous mitral repair after failed open surgery

Evaluated
Evaluation

Speaker: S. Kar(   )

19:30 - 19:45
Who are the best candidates for experimental TMVR in 2019?

Evaluated
Evaluation

Speaker: N. Kleiman(   )

19:45 - 20:00
Lessons from an International Registry on Transcatheter Tricuspid Thearapies

Evaluated
Evaluation

Speaker: F. Maisano

Chairmen: G. Athanassopoulos, G. Giamouzis, A. Trikas

04/05 Banquet Hall, MAICC
08:45 - 11:00
Mitral Session I – Complexities of Mitral Interventions 

Evaluated
Evaluation
08:45 - 09:00
Echocardiographic evaluation of the mitral valve. A guide to decision-making for transcatheter or surgical Repair / Replacement

Evaluated
Evaluation

Speaker: M. Chrissoheris(   )

09:00 - 09:15
Advanced Applications of CT Imaging for Transcatheter Mitral and Tricuspid Procedures

Evaluated
Evaluation

Speaker: C. Mourmouris

09:15 - 09:30
Mitral Valve-in-valve and valve-in-ring procedures. A long-needed necessity!

Evaluated
Evaluation

Speaker: A. Pitsis

09:30 - 09:45
Results of valve-in-MAC (mitral annular calcification) procedures. Assess and plan carefully!

Evaluated
Evaluation

Speaker: J. Velianou(   )

09:45 - 10:00
Currently enrolling TMVR and TTVR FIM and CE Mark trials

Evaluated
Evaluation

Speaker: S. Kar(   )

10:00 - 10:15
You can’t beat safety and simplicity: Edge to edge therapies will be the dominant strategy for mitral repair

Evaluated
Evaluation

Speaker: F. Maisano(   )

10:30 - 10:45
Live in a box Mitraclip

Evaluated
Evaluation
10:45 - 11:00
Discussion

Chairmen: L. Poulimenos, G. Stavridis, D. Tsiapras, M. Vavuranakis

Commentators: N. Baikoussis, K. Bellos, E. Petropoulou

11:00 - 13:00
TAVI Session IV – Avoiding Pitfalls 

Evaluated
Evaluation
11:00 - 11:15
A growing conundrum: Coronary access after TAVR. Difficulties, tips and tricks

Evaluated
Evaluation

Speaker: V. Voudris(   )

11:15 - 11:30
Mechanisms of coronary obstruction during and after TAVR: prediction, prevention, and treatment

Evaluated
Evaluation

Speaker: N. Van Mieghem(   )

11:30 - 11:45
Hybrid beating heart bypass grafting and TAVR. An excellent alternative?

Evaluated
Evaluation

Speaker: N. Bouboulis(   )

11:45 - 12:00
Guidelines and classification of bioprothetic TAVR and SAVR dysfunction and failure. Latest data on incidence, clinical impact and valve durability

Evaluated
Evaluation

Speaker: A. Manginas(   )

12:00 - 12:15
TAVR plus/minus AFib and/or CAD. Pharmacotherapy considerations, clinical trials and practical clinical recommendations

Evaluated
Evaluation

Speaker: R. Mehran(   )

12:15 - 12:30
The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

Evaluated
Evaluation

Speaker: G. Dangas(   )

12:30 - 12:45
Live-in-a-box TAVR

Evaluated
Evaluation
12:45 - 13:00
Discussion

Chairmen: D. Alexopoulos, I. Ikonomidis, A. Manginas, A. Pipilis

Commentators: N. Kadoglou, A. Roubelakis, G. Tsigas

13:00 - 13:30
BREAK 

13:30 - 15:00
TAVR Session V – Dealing with a “gray area”. Crucial questions and answers 

Evaluated
Evaluation
13:30 - 13:45
How far should we push the borderline transfemoral access for TAVR? Techniques, equipment, and likelihood of glory versus gory

Evaluated
Evaluation

Speaker: K. Spargias

13:45 - 14:00
To split or not to split? The role of BASILICA and LAMPOON as adjuvant procedures during TAVR and TMVR

Evaluated
Evaluation

Speaker: J. Velianou(   )

14:00 - 14:15
The rapid emergence of transcaval TAVR. Techniques and clinical outcomes

Evaluated
Evaluation

Speaker: M. Kasel(   )

14:15 - 14:30
TAVR in the decompensated patient with AS. How to evaluate and treat

Evaluated
Evaluation

Speaker: P. Dardas(   )

14:30 - 14:45
Live-in-a-box TAVR

Evaluated
Evaluation
14:45 - 15:00
Discussion

Chairmen: S. Konstantinidis, F. Mitropoulos, C. Olympios, K. Triantafillou

Commentators: P. Kalyvas, D. Ketikoglou, K. H. Papadopoulos

15:00 - 16:15
TAVR Session VI – Looking to the future. Innovative ideas in a rapidly-evolving domain 

Evaluated
Evaluation
15:00 - 15:10
Supra-annular TAVR devices. The real and possible advantages and disadvantages

Evaluated
Evaluation

Speaker: K. Spargias

15:10 - 15:20
The ACCURATE Neo TAVR system. Program Update, clinical data, patient selection and future vision

Evaluated
Evaluation

Speaker: A. Holzamer(   )

15:20 - 15:30
The PORTICO TAVR system. Program Update, clinical data, patient selection and future vision

Evaluated
Evaluation

Speaker: L. Michalis(   )

15:30 - 15:40
Medtronic Structural Heart Pipeline

Evaluated
Evaluation

Speaker: V. Martzaklis(   )

15:40 - 15:50
What to expect in the near future from the market leaders? The Sapien family and the CENTERA self-expandable valve. Program Update, clinical data and patient selection

Evaluated
Evaluation

Speaker: M. Kasel(   )

15:50 - 16:00
A Deep Dive Into TAVR Cost-Effectiveness Studies with constantly moving goalposts

Evaluated
Evaluation

Speaker: L. Michalis(   )

16:05 - 16:15
Discussion

Evaluated
Evaluation

Chairmen: G. Bompotis, A. Dimas, C. Kotoulas, S. Patsilinakos

Commentators: D. Damaskos, C. Moldovan, L. Poulimenos

16:15 - 16:30
BREAK 

16:30 - 17:30
JOINT SESSION  

SPECIAL LECTURES

Evaluated
Evaluation
16:30 - 16:50
TAVR device selection in the real world. Based on clinical, anatomical and device factors

Evaluated
Evaluation

Speaker: M. Kasel(   )

16:50 - 17:10
Three-Dimensional Echocardiography is key

Evaluated
Evaluation

Speaker: J. Kisslo

17:10 - 17:30
Patient selection for transcatheter tricuspid edge-to-edge grasping and clinical outcomes

Evaluated
Evaluation

Speaker: F. Maisano

Chairmen: A. Dagre, S. Pattakos

17:30 - 19:00
Mitral and Tricuspid Session II – Looking to the future 

Evaluated
Evaluation
17:30 - 17:45
Advanced echocardiography assessment of the tricuspid valve and right ventricular function and implications for transcatheter treatment

Evaluated
Evaluation

Speaker: M. Chrissoheris(   )

17:45 - 18:00
Technical tips and tricks to successful perform transseptal puncture for Mitraclip and TMVR procedures

Evaluated
Evaluation

Speaker: K. Spargias

18:00 - 18:15
An often Challenging MitraClip Decision: Whether to Implant a second (or third) Clip

Evaluated
Evaluation

Speaker: V. Ninios(   )

18:15 - 18:30
Transcatheter valve-in-valve and valve-in-ring in the tricuspid position. Patient selection, tips and tricks and outcomes

Evaluated
Evaluation

Speaker: A. Tzifa(   )

18:30 - 18:45
Minimally invasive surgery for isolated TR repair

Evaluated
Evaluation

Speaker: A. Pitsis

18:45 - 19:00
The Structural Heart and Valve Center: The Roles of Cardiovascular Team Professionals

Evaluated
Evaluation

Speaker: S. Pattakos(   )

Chairmen: N. Georgakopoulos, S. Kyrzopoulos, G. Makos, A. Patrianakos

Commentators: A. Manolis, S. Kounas, G. Moustogiannis

19:00 - 21:00
My best and/or my worst Structural Procedure of the year 

Evaluated
Evaluation
19:00 - 19:10

Evaluated
Evaluation

Speaker: C. Arampatzis(   )

19:10 - 19:20

Evaluated
Evaluation

Speaker: J. Iakovou(   )

19:20 - 19:30

Evaluated
Evaluation

Speakers: G. Katsimagklis(   ),

19:30 - 19:40

Evaluated
Evaluation

Speaker: D. Nikas

19:40 - 19:50

Evaluated
Evaluation

Speaker: V. Ninios

19:50 - 20:00

Evaluated
Evaluation

Speaker: K. Perreas(   )

20:00 - 20:10

Evaluated
Evaluation

Speaker: K. Spiliotopoulos(   )

20:10 - 20:20

Evaluated
Evaluation

Speaker: K. Triantafyllou(   )

20:20 - 20:30

Evaluated
Evaluation

Speaker: D. Tsikaderis(   )

20:30 - 20:40

Evaluated
Evaluation

Speaker: I. Zarifis(   )

Chairmen: N. Kafkas, A. Spanos, G. Triantis

Commentators: N. Koutsogiannis, M. Panagiotou, S. Papaioannou